The SEC Is Too Lax on CEO Health Disclosure
Company shareholders have a right to know when an executive's life hangs in the balance. As things now stand, Securities & Exchange Commission rules are exceedingly vague about what a company should disclose about the health of a C-level official, and how soon that disclosure should be made.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Smartphones Are Killing Americans, But Nobody’s Counting
- Why a Pub in the Middle of Nowhere Was Named the World’s Best Restaurant
- Gulf Coast Oil Spill May Be Largest Since 2010 BP Disaster
- Racist Outburst Prompts Faber’s Exit From Three Company Boards
- Airbus Snaps Up Bombardier Jet in New Challenge to Boeing